These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9798056)

  • 1. Highly active antiretroviral therapy decreases the incidence of bacteremia in human immunodeficiency virus-infected individuals.
    Tacconelli E; Tumbarello M; de Gaetano K; Cauda R; Ortona L
    Clin Infect Dis; 1998 Oct; 27(4):901-2. PubMed ID: 9798056
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.
    Revankar SG; Sanche SE; Dib OP; Caceres M; Patterson TF
    AIDS; 1998 Dec; 12(18):2511-3. PubMed ID: 9875598
    [No Abstract]   [Full Text] [Related]  

  • 3. Resolution of Mycobacterium avium complex bacteremia following highly active antiretroviral therapy.
    Hadad DJ; Lewi DS; Pignatari AC; Martins MC; Vitti Júnior W; Arbeit RD
    Clin Infect Dis; 1998 Mar; 26(3):758-9. PubMed ID: 9524856
    [No Abstract]   [Full Text] [Related]  

  • 4. Withdrawal of Mycobacterium avium complex suppressive therapy in HIV-1-infected patients on highly active antiretroviral therapy.
    Martínez E; Miró JM; González J; Mallolas J; Gatell JM
    AIDS; 1999 Jan; 13(1):147-8. PubMed ID: 10207565
    [No Abstract]   [Full Text] [Related]  

  • 5. Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy.
    Jiménez-Expósito MJ; Alonso-Villaverde C; Sardà P; Masana L
    AIDS; 1999 Jan; 13(1):152-3. PubMed ID: 10207569
    [No Abstract]   [Full Text] [Related]  

  • 6. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy.
    De Luca A; Ammassari A; Cingolani A; Giancola ML; Antinori A
    AIDS; 1998 Oct; 12(14):1937-8. PubMed ID: 9792402
    [No Abstract]   [Full Text] [Related]  

  • 7. Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient.
    Li TS; Tubiana R; Fillet AM; Autran B; Katlama C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):514-5. PubMed ID: 10225236
    [No Abstract]   [Full Text] [Related]  

  • 8. State of the art: antiretroviral and prophylactic treatments in HIV/AIDS.
    Porche DJ
    Nurs Clin North Am; 1999 Mar; 34(1):95-112. PubMed ID: 9922281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
    Rockstroh JK; Theisen A; Kaiser R; Sauerbruch T; Spengler U
    AIDS; 1998 May; 12(7):829-30. PubMed ID: 9619824
    [No Abstract]   [Full Text] [Related]  

  • 10. Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors.
    Tavel JA; Miller KD; Masur H
    Clin Infect Dis; 1999 Mar; 28(3):643-76. PubMed ID: 10194094
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-associated non-mycobacterial sepsis-bacteraemia, before and during the highly active antiretroviral therapy era.
    Manfredi R; Nanetti A; Ferri M; Chiodo F
    AIDS; 1999 Jul; 13(10):1274-6. PubMed ID: 10416534
    [No Abstract]   [Full Text] [Related]  

  • 12. Resolution of chronic parvovirus b19-induced anemia, by use of highly active antiretroviral therapy, in a patient with acquired immunodeficiency syndrome.
    Ware AJ; Moore T
    Clin Infect Dis; 2001 Apr; 32(7):E122-3. PubMed ID: 11264051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
    Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
    AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
    [No Abstract]   [Full Text] [Related]  

  • 15. Switch to an antiretroviral treatment of expected lower potency after effective highly active antiretroviral therapy (HAART).
    Manfredi R; Chiodo F
    J Acquir Immune Defic Syndr; 2000 Jan; 23(1):95-8. PubMed ID: 10708062
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of human immunodeficiency virus infection in pregnancy.
    Watts DH
    N Engl J Med; 2002 Jun; 346(24):1879-91. PubMed ID: 12063373
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy.
    Behrens GM; Meyer D; Stoll M; Schmidt RE
    Immunobiology; 2000 Aug; 202(2):186-93. PubMed ID: 10993293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological failure and adherence to antiretroviral therapy in HIV-infected patients.
    Rodríguez-Rosado R; Jiménez-Nácher I; Soriano V; Antón P; González-Lahoz J
    AIDS; 1998 Jun; 12(9):1112-3. PubMed ID: 9662214
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis and treatment of ocular viral infections in AIDS patients].
    Guex-Crosier Y
    Rev Med Suisse Romande; 1998 Nov; 118(11):941-7. PubMed ID: 9865123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.